Chemical formula: C₄₃H₅₃NO₁₄ Molecular mass: 807.879 g/mol PubChem compound: 148124
Docetaxel is an antineoplastic agent which acts by promoting the assembly of tubulin into stable microtubules and inhibits their disassembly which leads to a marked decrease of free tubulin.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01CD02 | Docetaxel | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DOCETAXEL TEVA Concentrate and solvent for solution | European Medicines Agency (EU) | MPI, EU: SmPC |
Docetaxel is an active ingredient of these brands:
United States (US)
Austria (AT)
Brazil (BR)Cyprus (CY)
Ecuador (EC)France (FR)
Ireland (IE)
Japan (JP)
Mexico (MX)
Netherlands (NL)
Singapore (SG)South Africa (ZA)Spain (ES)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
